Pharmaceutical news, Pharma industry, Pharmaceutical manufacturing

Top Headlines

Esketamine nasal spray for ‘debilitating mental illness’ recommended for approval

US FDA Psychopharmacologic Drug Advisory Committee recommends Spravato, an intranasal form of esketamine, for approval based on its favorable benefit-risk profile.

Mylan’s generic to cost 70% less then Advair

Mylan’s recently FDA-approved Advair Diskus generic to be offered at 70% cost reduction to its reference drug, and 67% less than GSK’s generic version.

With medicine tracking operational, what does this mean for industry?

Hugh Pullen, EMVO’s president, explains what the launching of the EMVS means for the industry, and details how a potential no-deal Brexit will impact the system.

FDA secures supply chain with pilot program testing tech

US FDA initiates a pilot project testing innovations in an aim to inform the development of the tracking and verification systems going into effect with the DCSA in 2023.